Department of Rheumatology, Basle University, Basel, Switzerland.
Clin Exp Rheumatol. 2009 Nov-Dec;27(6):1001-3.
We present an HIV-infected woman in whom antiretroviral treatment with tenofovir disoproxil fumarate (TDF) induced severe skeletal pain, synovial effusions and multiple fractures secondary to a Fanconi syndrome with hypophosphatemia and osteomalacia. TDF interferes with the replication of mitochondrial DNA in the proximal tubules of the kidney, which can explain the delayed onset of this form of renal phosphate loss. Nephrotoxicity had been precipitated by cotreatment with lopinavir/r, an HIV protease inhibitor which increases tenofovir serum levels and inhibits the tubular multidrug resistance protein 4, which is responsible for the efflux of tenofovir from tubular cells.Awareness is needed to link the typically prolonged onset of clinical symptoms with TDF exposure and then establish the correct diagnosis.
我们报告了一例 HIV 感染女性患者,她在使用富马酸替诺福韦二吡呋酯(TDF)进行抗逆转录病毒治疗后,发生范可尼综合征导致严重的骨骼疼痛、关节积液和多处骨折,同时伴有低磷血症和骨软化症。TDF 可干扰近端肾小管中线粒体 DNA 的复制,这可以解释这种形式的肾磷酸盐丢失延迟发生的原因。洛匹那韦/利托那韦的联合治疗促使了肾毒性的发生,因为 HIV 蛋白酶抑制剂洛匹那韦/利托那韦会增加替诺福韦的血清水平并抑制肾小管多药耐药蛋白 4,后者负责替诺福韦从肾小管细胞中流出。需要注意的是,典型的临床症状延迟出现与 TDF 暴露有关,然后才能建立正确的诊断。